[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-COAG":3,"homepage-market-summary":29,"stock-news-COAG":170},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":14},"COAG","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":9,"headquarters":12,"founded":9,"is_fund":13,"issuer":9,"category":9},"Hemab Therapeutics Holdings, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.","Cambridge, MA",false,{"close":15,"open":16,"high":16,"low":17,"prev_close":18,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":25,"avg_volume_52w":26,"range_52w_percent":27,"record_count":28},31.11,31.49,30.06,31.06,0.05,0.16,354144.505495,7996,30.7801,55.42,23,413730.78099455143,25,107,{"status":30,"indices":31,"watchlist":74,"sectors":96,"benchmarks":152},"success",[32,40,47,54,61,67],{"symbol":33,"name":34,"price":35,"change":36,"pct_change":37,"is_up":38,"sparkline":39,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":41,"name":42,"price":43,"change":44,"pct_change":45,"is_up":38,"sparkline":46,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":48,"name":49,"price":50,"change":51,"pct_change":52,"is_up":38,"sparkline":53,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":55,"name":56,"price":57,"change":58,"pct_change":59,"is_up":38,"sparkline":60,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":62,"name":63,"price":64,"change":27,"pct_change":65,"is_up":38,"sparkline":66,"date":5},"RUT","RUSSELL 2000",2815.2,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":13,"sparkline":73,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[75,82,89],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":38,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":38,"sparkline":88,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":38,"sparkline":95,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[97,102,107,112,117,122,127,132,137,142,147],{"name":98,"etf":99,"change":100,"price":101,"is_up":38},"Technology","XLK",1.01,199.81,{"name":103,"etf":104,"change":105,"price":106,"is_up":38},"Financials","XLF",0.06,53.49,{"name":108,"etf":109,"change":110,"price":111,"is_up":13},"Healthcare","XLV",-0.01,166.18,{"name":113,"etf":114,"change":115,"price":116,"is_up":38},"Consumer Cycl","XLY",1.13,110.04,{"name":118,"etf":119,"change":120,"price":121,"is_up":38},"Consumer Staples","XLP",0.25,80.53,{"name":123,"etf":124,"change":125,"price":126,"is_up":38},"Energy","XLE",0.4,62.95,{"name":128,"etf":129,"change":130,"price":131,"is_up":38},"Industrials","XLI",0.78,169.95,{"name":133,"etf":134,"change":135,"price":136,"is_up":38},"Materials","XLB",0.66,48.86,{"name":138,"etf":139,"change":140,"price":141,"is_up":38},"Real Estate","XLRE",0.32,40.81,{"name":143,"etf":144,"change":145,"price":146,"is_up":38},"Utilities","XLU",0.38,39.83,{"name":148,"etf":149,"change":150,"price":151,"is_up":38},"Comm Services","XLC",0.35,110.32,[153,158,162,166],{"ticker":154,"name":155,"price":156,"change":157,"is_up":38},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":159,"name":160,"price":161,"change":87,"is_up":38},"QQQ","Invesco QQQ Trust",749.58,{"ticker":163,"name":164,"price":165,"change":52,"is_up":38},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":167,"name":168,"price":169,"change":65,"is_up":38},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":171,"articles":172},14,[173,179,185,191,197,203,209,214,219,224,229,234,239,244],{"title":174,"link":175,"pubDate":176,"description":177,"source":178},"Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxPc01HTjZyMlRqdUw2QjhieW1PWnZVbFN0MktMb2swenNYcTVGUFJYWklzYV90ZTgxc0ttUXBuNmhDOFg4b0QzZ3p1N3NxUkV6cEItT2w0QldYT2VVbTBad1dLWWs1ZlRnTmRFdWlwWUFUb3lLUHl3YmF1dE9ZcUtTajRTemU4SGNiNUZHR2NiaEE0VTdxV1YxOGVlal96NDBKREhST3ZR?oc=5","Tue, 29 Sep 2026 01:07:00 GMT","Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? Yahoo Finance","Yahoo Finance",{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"Hemab Therapeutics Holdings (Nasdaq:COAG) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPUklvM0ViaTU4QnQ1UG96bmtwVXVvMTI4bkJzYW5uWTEybVNhM2xsUG5oa01FOXhWaGRTMENUNXN4RUF2bnlkV040c3NnTzJpWVZtOFRST2N4enRDSGh6U0lpa25nQUFqa1JSUmhBODRzWjFJeFBYaDZnQTFGWW5ma3JVMjUxdEVkUXhCYmZ6RXhidl9VaS1VVTNwbw?oc=5","Sun, 20 Sep 2026 07:00:00 GMT","Hemab Therapeutics Holdings (Nasdaq:COAG) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"$COAG stock is down 8% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxPS0V4MGw0X2xZeFhxLUk3eVo5WUo3UDZhNmNlTEFHV0FkWFdhMlRKV1NCYVprZFR5MERyYzhCNm5uZzliTGNEcmJzMjBUcTN2dm5Yd2FvYnh5Ui1ZMHRSeW00TnN5Nk1pN1NIZmRpM3NXRU84ZnhreTBkT2ROR3BGZlVweXVkMzJBOEVlRlF4dGVjR3FBdG50MEI0bHNMa3ppWUE?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","$COAG stock is down 8% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"Director Walbert Keli's option carries a $35.72 exercise price at Hemab Therapeutics (COAG). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxOa3hnRlU2SVVKTkx3M0x0NVphQ2NtYnJsSkttdjdkQVhZaUhGa2lEXy11SEIzc0xZTW0tYTR2ZkswaGh2ei14VGJtdEdOdGxGMjZweEdUSWVMakdQbnE5VkF5ZTNwU3NVNEwyUU1YdjYweWYtbjRJRjJXa25lMS1jODZRcnJmUWRXWnJFYllNbmpGc2ZfUTEzZ0lzLW9zVmZiMGd3Y0hYaWRieTk3Z0hDSFBkRnNSaHgyOU5GbmtfbGRhNXM?oc=5","Fri, 25 Sep 2026 20:46:41 GMT","Director Walbert Keli's option carries a $35.72 exercise price at Hemab Therapeutics (COAG). Stock Titan","Stock Titan",{"title":198,"link":199,"pubDate":200,"description":201,"source":202},"Hemab Therapeutics (NASDAQ:COAG) Shares Gap Down - Here's What Happened - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPVlVoUlYyMjljSVlWMkdPQ0Q5RFNtV3RsN1RuTUdlY0o3QnV1bkR4bVJaTTN5Vml5VkF4ZHVrSGw1VFJNUGdEa2FHV0VDZ0Z0ZGtSZ1F3WWQ3T0pLSHotVndiM043Zkh3cmxPdFdXNk54QTFYSmFxSkxqdnR5eW4zS0pNWFF1RjJIZTBiQjFpY2drMEplZUtIa3JXSEQ3aklkVHczZlo2SlVnZmtwLUtRaE5iSHBlX251MHMtU1dLOGlidldQ?oc=5","Thu, 01 Oct 2026 16:29:27 GMT","Hemab Therapeutics (NASDAQ:COAG) Shares Gap Down - Here's What Happened MarketBeat","MarketBeat",{"title":204,"link":205,"pubDate":206,"description":207,"source":208},"Hemab Therapeutics: The Market Is Pricing One Rung Of A Four-Rung Ladder (NASDAQ:COAG) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQcVZsVXh6b1BDVFdxcW5QZ3B3eVhiTFg3ZEF4dF8ySWhsTTE3b3FKdUg1Q0lFWDJLRzhBcEFtdGIxbUVCeU15X2pzMGs0Q1JpdFJHVmYxX3pwZ1MyVUVKdmE4ajBaWlg3SW5TdXlKd0JlblZjdEZ2NFJwLTlWcGlobG9aTGpRcjFZYTNzQUlHb0MwNHMwYW5va0RRQlJUbVlOWkRHYWliT2F4YndIcW5jTnZR?oc=5","Tue, 29 Sep 2026 16:08:37 GMT","Hemab Therapeutics: The Market Is Pricing One Rung Of A Four-Rung Ladder (NASDAQ:COAG) Seeking Alpha","Seeking Alpha",{"title":210,"link":211,"pubDate":212,"description":213,"source":196},"Walbert Keli is listed as a director of Hemab Therapeutics (COAG) in an initial ownership statement. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxQUVUzc2RZaVctbGVKWVFyTnh1NVZrd2lqQ0ZYX0t1cy03aEtOODdrZThuV1VCODVZUXVwY1d3MFh6VnczQVdQWUtVQUxwcV92V1Z3SFZNMk5YTHlDOFFUakRFYTRadUVsUXZkS1RiRDZXb1JWV0VoQng2NkE5d2dDY0Q4MmpNYkRCNEI1RW5YRGE5ZWlXVUdLT3dMbm5NVTVrTkQ5RUJsazk2MElGMkhzXzUzejhsYWI0N3hIQ1JCWERqdHNKOTBTaV9PNA?oc=5","Fri, 25 Sep 2026 20:43:49 GMT","Walbert Keli is listed as a director of Hemab Therapeutics (COAG) in an initial ownership statement. Stock Titan",{"title":215,"link":216,"pubDate":217,"description":218,"source":184},"Can Hemab Therapeutics Holdings (COAG) Justify Its Valuation After Russell Index Inclusion? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 23 Sep 2026 14:37:30 GMT","Can Hemab Therapeutics Holdings (COAG) Justify Its Valuation After Russell Index Inclusion? Simply Wall Street",{"title":220,"link":221,"pubDate":182,"description":222,"source":223},"Hemab Therapeutics Holdings, Inc.(NasdaqGS: COAG) added to S&P Global BMI Index - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxNY1BIb2lQUFRoN2tRbGE5YzIzZ3lvSXpzTEFsLXBaNVV0b0xsSVoxN2p6Y1lKS1FNM3Fwd2JnQUVHNDhfSkl3Z2Utc3BvM2pPVWNXM0ZqYmJrY1NLb0RERzVRb3RjcUp2SkpSdWlzc0dZSW9obGhpbzE3OWE4UE1XelF4WW5PcnpvZTE2Umc3SEZaLUpsYmNLMUVRYnl0OHdoVkJMc1VqVF9OaEFnOXVOSEpod1REczRUcWhWamp4aDZPZWNwT3lF?oc=5","Hemab Therapeutics Holdings, Inc.(NasdaqGS: COAG) added to S&P Global BMI Index marketscreener.com","marketscreener.com",{"title":225,"link":226,"pubDate":227,"description":228,"source":202},"Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxNNWdIeHgwOW5reEhhWWVONnhnM2lfc1dnUy1aeFRTaVpfM1M0VzB3c21tMjVxbFlSZ2JHNHFkM3BrbVF3bGJZV1l3cnBYc0FOS05oQlVzdGJjdUVRTHRLZWs0d0FZZ3RPNm9Va3pLZkcxd1FJR2ZlTUdOQ0MwUExKZjBBOGtWSUVEZ2Q0Sy1LT0NCRUVKdDVOTFJSZmJSaGZWbkVKZV82TkhVT3hncHRPTkh4VFZudl9VZFowRjdTem10Nm1vMFZSNkt2eTFkbXVIU253?oc=5","Wed, 30 Sep 2026 16:03:18 GMT","Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy? MarketBeat",{"title":230,"link":231,"pubDate":232,"description":233,"source":202},"Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of \"Moderate Buy\" from Analysts - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi9gFBVV95cUxQdTlDS0tDYmlvMlNZYmZva1BWOWx0WDVZb1pVS3I5R29NYzU2UkRrTGJOeDIzUGo2QkVMSzhxNEloQWE5aGh2UURwTlBHMWt4dTFWMjh2S0djOXV5NWdMOTJ0amJBTXV3bGNFOFd3dm5RajZJVG9HcjV2MHo0TWFnaGdKaWlZRWQyM3NOQ1FWV2xLWFRxNWk4ZDVHbnV1aEY5eVE5SXNuNkJmV0doakc0X0NYaTlaQU1PUXhfY2daVWppb2tYLTA0bjNaQWg4UXpibDhwN20zWXlFY0gzWFltTzNkME9FYnQ0ZXV3eUVJemYtLWY2cWc?oc=5","Thu, 01 Oct 2026 10:19:09 GMT","Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of \"Moderate Buy\" from Analysts MarketBeat",{"title":235,"link":236,"pubDate":237,"description":238,"source":184},"Hemab Therapeutics Holdings (COAG) Begins Phase 1 Dosing For HMB 003 - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8wFBVV95cUxQWHpFR1BEdnJfZnpXLXBwS1RyLXVDa1FzMjFqQ0FBZDU5dThxRmhzSURHTExKQlpBaFhkamJiZTB0Q0dmc1M0TkhhMUdhZDJUSnJVLU1saE5LMTVjRFVXS1FUdG1QSGF4RjhaTDBIN1hGNjZORF9nWUwzTV80eUxzd1VSZ2ktUkE5bTBPQXk4MkUtNUY2YWJNLXNDbjFLdXF6RUw5eFhfRkdrMnNxUTVVc3pzS2tWQVY5M0Y4RnBBS0xXbWM5Q182bmZ6bzJJdUxqeXBYQlhFQTZuY0VjTzJVSTVaVF9fQmlYNU9KaEUtRG5LMkXSAfgBQVVfeXFMTWZ6N1lWRHdmVnNJZjJ2UWRuR3R0Y21WcUV4RTVQS0I2UEhHdWdjU09xUXowWTZrOEw2aG1KZnpGbHFwZ2E2cWl2ZUZHYndMcTI3SVctWXZoczEyakI5dnJhTi1CRzJiYjk3N3JydkpNczVleFQyY0FmQWxmMDh1Z0NWQ2RlWGRXY01lTE9KMk01R3J2S05EY2ExbGlrQjljUUpIY3FHM3d5QVFUdndwdTI5NXhxNXp3Mkhrbm9KYV9GWm8yc3FmMjltS0tXT3VrVDlIUEpHdWE5V0w1bTR4cFpma2JqT210aG1aYlljaXpMYWhXQzlZQVA?oc=5","Sat, 26 Sep 2026 20:25:44 GMT","Hemab Therapeutics Holdings (COAG) Begins Phase 1 Dosing For HMB 003 Simply Wall Street",{"title":240,"link":241,"pubDate":242,"description":243,"source":202},"76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxOVGQxeTE2eW8xbXJnSU9kUlEzXzYyM0FtdGNvUjQ0TzZnNlJlaHpGZzNibWNDOWhhSGJSNDNfLWpNWHdWY0hpQm1ydWRjZTBVWjFIVFdWdVhZMUZQQmhEU2FQYy1kNmNhc0k1UWt5UHQtZHBTWVZnWUpod0FubTZjSVVaNmNINFZsZnZIRk4xdThsRmVZU0d4UVM0QmRGUnAtal9fU0k2N1NEOWZ4VTVUVUkybEo4aUdjUEdiM2QzNmY1RjQ1S18zbXNvd2p5QU5yc1V0YlBaUDM?oc=5","Sun, 27 Sep 2026 07:36:57 GMT","76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp MarketBeat",{"title":245,"link":246,"pubDate":247,"description":248,"source":202},"Hemab Therapeutics (NASDAQ:COAG) Shares Down 5.7% - What's Next? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxNSi05aVRHT0hjN3Y5UGxjSVdQejNMZnhVZi1rVnQ0ZXVISUN3M0RPTG9xVVJheDRFX3ZndFM4Q0ltQ1d2bHhjQkVvY0FFZlY4NlNjSFRobkNlRTVzTGpOMV9sOFpjQ0Y2aWkxNUYza2JJQ0VuYk52T2prRFRlWDdEV2JQS0x5SkZnOXJEcS15X2F5VUFhRm11bDBISXlpWlRYbEFLWUdzOWxTa0lDa09pbnFnTGc2Q28?oc=5","Mon, 21 Sep 2026 17:03:02 GMT","Hemab Therapeutics (NASDAQ:COAG) Shares Down 5.7% - What's Next? MarketBeat"]